Norton Heart & Vascular Institute
Norton Healthcare Services
Learn more about Norton Healthcare services and resources for providers
Norton Children's Services
Learn more about Norton Children's services and resources for providers
Continuing Medical Education
CME opportunities for pediatric and adult care
News and insights from the Louisville area’s leading cardiovascular disease prevention and treatment program. The institute provides diagnostic, medical, interventional and surgical care at Norton Healthcare’s accredited chest pain and stroke centers, as well as numerous outpatient offices.
Provider Spotlight
Shawn W. Adams, M.D.
After spinal fellowships in the latest surgical techniques, Shawn W. Adams, M.D., has joined Norton Leatherman Spine and Norton Neuroscience Institute.
September 2023 Norton Medical Group new providers
Paul A. Adams, M.D. Emergency Medicine Matthew P. Allinder, M.D. Emergency Medicine Austin C. Baker, M.D. Emergency Medicine Jared S. Bass, D.O. Emergency Medicine Shannon M. Becht, M.D. Emergency Medicine Kristen Bublitz, D.O. Emergency Medicine […]
Read Full Story
Shawn W. Adams, M.D., joins Norton Leatherman Spine
After completing a pair of spinal fellowships in the latest surgical techniques and technologies, Shawn W. Adams, M.D., has joined Norton Leatherman Spine and Norton Neuroscience Institute. Dr. Adams’ fellowships covered complex adult spine, deformity [...]
Read Full Story
Tzield may delay Stage 3 Type 1 diabetes in adults and children
Recently approved Tzield (teplizumab-mzwv), is delivering breakthrough results that suggest it may delay the onset of Stage 3 Type 1 diabetes by an average of two years. The first-in-class drug is approved for adults and […]
Read Full Story
Ultra-fast-acting inhaled insulin, Afrezza, trialed at Norton Children’s Endocrinology
Afrezza inhaled insulin, currently approved for adults, is being tested for children in a clinical trial at Wendy Novak Diabetes Institute, a part of Norton Children’s Endocrinology, affiliated with the UofL School of Medicine. Norton […]
Read Full Story
DFMO medulloblastoma clinical trial examines drug’s effectiveness for high-risk cases
Researchers are recruiting pediatric medulloblastoma patients for a novel use of difluoromethylornithine (DFMO) to prevent relapse. The multisite study, sponsored by the Beat Childhood Cancer Consortium and led by Michael Angelo C. Huang, M.D., pediatric [...]
Read Full Story